Teachers Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Teachers Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$130M	Buy	907,496 +196,047	+28%	+$25.6M	0.16%	120
2018 Q4	$88.2M	Buy	711,449 +21,040	+3%	+$3.12M	0.12%	164
2018 Q3	$116M	Buy	690,409 +4,217	+0.6%	+$725K	0.14%	145
2018 Q2	$118M	Buy	686,192 +27,936	+4%	+$4.57M	0.15%	129
2018 Q1	$99.4M	Buy	658,256 +56,471	+9%	+$8.28M	0.13%	168
2017 Q4	$81M	Buy	601,785 +83,426	+16%	+$11.6M	0.1%	220
2017 Q3	$75.8M	Buy	518,359 +152,263	+42%	+$23M	0.1%	226
2017 Q2	$56.9M	Buy	366,096 +39,179	+12%	+$5.99M	0.08%	310
2017 Q1	$47.4M	Buy	326,917 +175,861	+116%	+$22.9M	0.07%	346
2016 Q4	$16.5M	Buy	151,056 +13,119	+10%	+$1.46M	0.03%	732
2016 Q3	$16.8M	Buy	137,937 +1,140	+0.8%	+$154K	0.03%	678
2016 Q2	$19.3M	Sell	136,797 -114,494	-46%	-$16.9M	0.03%	566
2016 Q1	$32.8M	Sell	251,291 -53,013	-17%	-$6.6M	0.06%	398
2015 Q4	$42.8M	Buy	304,304 +18,469	+6%	+$2.56M	0.08%	313
2015 Q3	$38M	Buy	285,835 +622	+0.2%	+$107K	0.08%	339
2015 Q2	$50.2M	Buy	285,213 +1,069	+0.4%	+$192K	0.09%	282
2015 Q1	$49.1M	Sell	284,144 -17,773	-6%	-$3.05M	0.09%	294
2014 Q4	$49.4M	Buy	301,917 +126,082	+72%	+$20.9M	0.09%	278
2014 Q3	$28.2M	Sell	175,835 -889	-0.5%	-$137K	0.06%	423
2014 Q2	$26M	Sell	176,724 -27,442	-13%	-$3.81M	0.05%	467
2014 Q1	$28.3M	Sell	204,166 -66,395	-25%	-$9.99M	0.06%	425
2013 Q4	$34.2M	Sell	270,561 -88,279	-25%	-$9.14M	0.08%	331
2013 Q3	$33M	Buy	358,840 +61,139	+21%	+$4.93M	0.08%	309
2013 Q2	$20.5M	Buy	+297,701	New	+$18.2M	0.05%	441

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Teachers Advisors's JAZZ Position: Q1 2019 in Review

Teachers Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 28% in Q1 2019, buying an estimated $25.6M and bringing the position to 907,496 shares worth $130M. The position accounts for 0.16% of the portfolio, ranked #120.

Teachers Advisors first reported a position in JAZZ in Q2 2013 and has held it in 24 quarters since. 427 funds tracked by Wall St. Rank hold JAZZ as of Q1 2019.

Teachers Advisors held 907,496 shares of Jazz Pharmaceuticals worth $130M as of Q1 2019.
Teachers Advisors bought 196,047 Jazz Pharmaceuticals shares in Q1 2019, an estimated $25.6M.
Jazz Pharmaceuticals made up 0.16% of Teachers Advisors's portfolio in Q1 2019, its #120 holding.
Teachers Advisors first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
427 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.